Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
New Nordic Healthbrands ABFRA:N9X -2.10%63 5-Year Yield-on-Cost % is 1.38 as of Aug. 15, 2026, which is 49% below its 10-year median of 2.71. GuruFocus rates FRA:N9X with a GF Score™ of 63/100 and a GF Value™ of €1.73. The stock has 4 warning signs investors should review. Among 1,161 Consumer Packaged Goods companies, New Nordic Healthbrands AB ranks worse than 78.64% on this metric.
The historical rank and industry rank for New Nordic Healthbrands AB's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:N9X'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.54 Med: 2.71 Max: 6.1
Current: 1.38
During the past 13 years, New Nordic Healthbrands AB's highest Yield on Cost was 6.10. The lowest was 0.54. And the median was 2.71.
FRA:N9X's 5-Year Yield-on-Cost % is ranked worse than 78.64% of 1161
companies
in the Consumer Packaged Goods industry
Industry Median: 3.42
vs FRA:N9X: 1.38
New Nordic Healthbrands AB (FRA:N9X) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
New Nordic Healthbrands AB 5-Year Yield-on-Cost % Related Terms
FRA:N9X vs KHC, GIS, HRL: 5-Year Yield-on-Cost % Comparison
For the Packaged Foods subindustry, New Nordic Healthbrands AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's 5-Year Yield-on-Cost % falls into.
New Nordic Healthbrands AB 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
New Nordic Healthbrands AB (FRA:N9X) has a 5-Year Yield-on-Cost % of 1.38 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on New Nordic Healthbrands AB and its competitors. This is 49% below median its historical median of 2.71. Over the past decade, New Nordic Healthbrands AB's 5-Year Yield-on-Cost % has ranged from 0.54 to 6.10. According to the industry distribution chart, New Nordic Healthbrands AB ranks #913 out of 1161 companies in the Consumer Packaged Goods industry, placing it in the top 78.6%.
Is New Nordic Healthbrands AB's 5-Year Yield-on-Cost % too high?
New Nordic Healthbrands AB's current 5-Year Yield-on-Cost % of 1.38 is 49% below median its 10-year median of 2.71. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 6.10. The Consumer Packaged Goods industry median 5-Year Yield-on-Cost % is 3.42. New Nordic Healthbrands AB's value of 1.38 is 59.6% below this industry median. Based on the distribution chart, New Nordic Healthbrands AB ranks #913 out of 1161 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, New Nordic Healthbrands AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's 5-Year Yield-on-Cost % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #913 out of 1161 companies for 5-Year Yield-on-Cost %. This places New Nordic Healthbrands AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.42. New Nordic Healthbrands AB's value of 1.38 is 59.6% below this benchmark. Historically, New Nordic Healthbrands AB's own 5-Year Yield-on-Cost % has ranged from 0.54 to 6.10 over the past decade. While the company's 10-year median is 2.71 vs. the industry median of 3.42, New Nordic Healthbrands AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.42, based on 1,161 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. New Nordic Healthbrands AB's current 5-Year Yield-on-Cost % of 1.38 is 59.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current 5-Year Yield-on-Cost % is 1.38, which is 49% below median its own 10-year median of 2.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current 5-Year Yield-on-Cost % of 1.38. The stock's GF Value™ is €1.73, compared to a current price of €1.64 — trading 5.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.38, which is 49% below median its 10-year median of 2.71 and 59.6% below the Consumer Packaged Goods industry median of 3.42. New Nordic Healthbrands AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current 5-Year Yield-on-Cost % is 1.38 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.64 is trading 5.5% below its estimated GF Value™ of €1.73.
Key valuation signals for FRA:N9X:
5-Year Yield-on-Cost %: 1.38 (49% below median its 10-year median of 2.71)
GF Value™: €1.73 vs. price of €1.64 (5.5% below fair value)
Industry Position: 59.6% below the Consumer Packaged Goods median (#913 of 1161)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
63GF Score
Get the complete analysis for FRA:N9X
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
